Kronos Bio Stock (NASDAQ: KRON) stock price, news, charts, stock research, profile.
You can purchase shares of Kronos Bio (NASDAQ:KRON) through any online brokerage.
Other companies in Kronos Bio’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Kronos Bio has a consensus price target of $7.31.
The stock price for Kronos Bio (NASDAQ: KRON) is $0.9503 last updated January 15, 2025 at 9:25 AM EST.
There are no upcoming dividends for Kronos Bio.
Kronos Bio’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Kronos Bio.
Kronos Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.